Search research articles
Contact Us
Filters
Showing results (141-150 of 169) with videos related to
Page
of 17
Sort By:
Frontiers in Oncology
|
May 31, 2021
Individualized Nomogram for Predicting Survival in Patients with Brain Metastases After Stereotactic Radiosurgery Utilizing Driver Gene Mutations and Volumetric Surrogates
Cheng Zhou, Changguo Shan, Mingyao Lai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
Feng-Ming Spring Kong, Vitali Moiseenko, Jing Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus
Feng-Ming Spring Kong, Timothy Ritter, Douglas J Quint, et al.
JAMA Oncology
|
September 26, 2024
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma
Chi Leung Chiang, Kenneth Sik Kwan Chan, Keith Wan Hang Chiu, et al.
Journal of the National Cancer Center
|
April 20, 2026
Differential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China
Si-Chao Wang, Zheng-Hao Ye, Han Zhou, et al.
Journal of the National Cancer Center
|
March 5, 2025
Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma
Cai-Ning Zhao, Chi-Leung Chiang, Wan-Hang Keith Chiu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 23, 2020
Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer
Yongmei Liu, Weili Wang, Kevin Shiue, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2017
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship
Peter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 23, 2023
Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation
Geng-Min Niu, Miao-Miao Gao, Xiao-Feng Wang, et al.
Signal Transduction and Targeted Therapy
|
May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming
Laiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 169) with videos related to
Sort By:
Page
of 17
Frontiers in Oncology
|
May 31, 2021
Individualized Nomogram for Predicting Survival in Patients with Brain Metastases After Stereotactic Radiosurgery Utilizing Driver Gene Mutations and Volumetric Surrogates
Cheng Zhou, Changguo Shan, Mingyao Lai, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 30, 2018
Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
Feng-Ming Spring Kong, Vitali Moiseenko, Jing Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus
Feng-Ming Spring Kong, Timothy Ritter, Douglas J Quint, et al.
JAMA Oncology
|
September 26, 2024
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma
Chi Leung Chiang, Kenneth Sik Kwan Chan, Keith Wan Hang Chiu, et al.
Journal of the National Cancer Center
|
April 20, 2026
Differential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China
Si-Chao Wang, Zheng-Hao Ye, Han Zhou, et al.
Journal of the National Cancer Center
|
March 5, 2025
Treatments of transarterial chemoembolization (TACE), stereotactic body radiotherapy (SBRT) and immunotherapy reshape the systemic tumor immune environment (STIE) in patients with unresectable hepatocellular carcinoma
Cai-Ning Zhao, Chi-Leung Chiang, Wan-Hang Keith Chiu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 23, 2020
Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer
Yongmei Liu, Weili Wang, Kevin Shiue, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 27, 2017
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationship
Peter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 23, 2023
Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation
Geng-Min Niu, Miao-Miao Gao, Xiao-Feng Wang, et al.
Signal Transduction and Targeted Therapy
|
May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming
Laiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Page
of 17